Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
12,472,096
-
Shares change
-
+726,297
-
Total reported value, excl. options
-
$4,111,281,844
-
Value change
-
+$498,327,735
-
Put/Call ratio
-
46%
-
Number of buys
-
121
-
Number of sells
-
-55
-
Price
-
$329.79
Significant Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q1 2014
199 filings reported holding ICPT - INTERCEPT PHARMACEUTICALS IN - COM as of Q1 2014.
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) has 169 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,472,096 shares
.
Largest 10 shareholders include FMR LLC (2,889,269 shares), ORBIMED ADVISORS LLC (1,734,934 shares), JENNISON ASSOCIATES LLC (1,138,177 shares), Capital World Investors (1,004,751 shares), VANGUARD GROUP INC (580,699 shares), PRICE T ROWE ASSOCIATES INC /MD/ (567,640 shares), Viking Global Investors LP (454,917 shares), BAKER BROS. ADVISORS LP (256,375 shares), BlackRock Institutional Trust Company, N.A. (234,731 shares), and BlackRock Fund Advisors (200,442 shares).
This table shows the top 169 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.